{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:44:09Z","timestamp":1791639849241,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clon.2025.103907","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:49:08Z","timestamp":1754668148000},"page":"103907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy\/ 20 F vs 45 Gy\/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial)"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-1399","authenticated-orcid":false,"given":"Pittaya","family":"Dankulchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-8861","authenticated-orcid":false,"given":"Tissana","family":"Prasartseree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwatchai","family":"Sittiwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-8874","authenticated-orcid":false,"given":"Kullathorn","family":"Thephamongkhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchayut","family":"Nakkrasae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2025.103907_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2020.06.054","article-title":"Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development","volume":"108","author":"Thomson","year":"2020","journal-title":"International Journal of Radiation Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2025.103907_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000827","article-title":"ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies","volume":"5","author":"Colombo","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.clon.2025.103907_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2020.06.486","article-title":"Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations","volume":"158","author":"Elledge","year":"2020","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/ijgc-2021-003001","article-title":"Global challenges of radiotherapy for the treatment of locally advanced cervical cancer","volume":"32","author":"Mayadev","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2021.10.036","article-title":"Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries","volume":"525","author":"Zhao","year":"2022","journal-title":"Cancer Letters"},{"key":"10.1016\/j.clon.2025.103907_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.brachy.2019.02.007","article-title":"Radiobiological dose calculation parameters for cervix cancer brachytherapy: A systematic review","volume":"18","author":"Chow","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2025.103907_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumour dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1748-717X-6-176","article-title":"Apoptosis induction and tumour cell repopulation: The yin and yang of radiotherapy","volume":"6","author":"Lauber","year":"2011","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: an important cause of treatment failure","volume":"5","author":"Kim","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib10","first-page":"238","article-title":"Fractionation in Radiation Therapy of Carcinoma of the Uterine Cervix: Results of Prospective Study of 3 VS. 5 Fractions per Week 1","volume":"3","author":"Marcial","year":"1968"},{"key":"10.1016\/j.clon.2025.103907_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ijrobp.2004.04.053","article-title":"Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: A phase I-II study","volume":"60","author":"Viegas","year":"2004","journal-title":"International Journal of Radiation Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2025.103907_bib12","series-title":"A retrospective study of advanced carcinoma of the cervix treated with a hypofractionated radiation therapy protocol at the department of radiation oncology","author":"Komen","year":"2014"},{"key":"10.1016\/j.clon.2025.103907_bib13","first-page":"112","article-title":"Study of comparison of outcome between conventional versus hypofracti onated radical radiotherapy alongwith Cisplatin as a Radiosensitizer in Stage IIIB cancer cervix","volume":"5","author":"Mahobia","year":"2015","journal-title":"IJBMR"},{"key":"10.1016\/j.clon.2025.103907_bib14","first-page":"2809","article-title":"Hypofractionated Radiotherapy With Concurrent Weekly Cisplatin Vs Conventional Radiotherapy with Concurrent Weekly Cisplatin in Advanced Carcinoma Cervix","volume":"5","author":"Mishra","year":"2017","journal-title":"SJAMS"},{"key":"10.1016\/j.clon.2025.103907_bib15","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.14260\/jemds\/2019\/418","article-title":"A STUDY COMPARING THREE DIFFERENT CHEMO-RADIATION TECHNIQUES IN MANAGEMENT OF CERVICAL CANCER","volume":"8","author":"Ghorai","year":"2019","journal-title":"Jemds"},{"key":"10.1016\/j.clon.2025.103907_bib16","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.ijrobp.2022.07.500","article-title":"A Pilot Study of Moderately Hypo-Fractionated Whole Pelvic Radiotherapy with Concurrent Chemotherapy and Image-Guided High Dose Rate Brachytherapy for Locally Advanced Cervical Carcinoma","volume":"114","author":"Gandhi","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.clon.2025.103907_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00432-023-05563-8","article-title":"Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomised controlled clinical trial","volume":"150","author":"Maddah Safaei","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clon.2025.103907_bib18","first-page":"253","article-title":"Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria","volume":"29","author":"Campbell","year":"2000","journal-title":"Afr J Med Med Sci"},{"key":"10.1016\/j.clon.2025.103907_bib19","first-page":"127","article-title":"Hypofractionated radiotherapy in carcinoma cervix IIIB: Tata Memorial Hospital experience","volume":"39","author":"Muckaden","year":"2002","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.22214\/ijraset.2020.31385","article-title":"A Relative Investigation among Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in the Locoregional Control of Carcinoma of the Cervix","volume":"8","author":"Khatun","year":"2020","journal-title":"IJRASET"},{"key":"10.1016\/j.clon.2025.103907_bib21","article-title":"A Retrospective Analysis of the Impact of HIV Infection on Outcomes of Locally Advanced Cervical Cancers Treated With Either Conventional or Hypofractionated Radiotherapy: The Uganda Experience","volume":"8","author":"Kavuma","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clon.2025.103907_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.08.003","article-title":"Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience","author":"Dankulchai","year":"2024","journal-title":"Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib24","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2025.103907_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5114\/jcb.2020.100377","article-title":"Excess dose-related parameters (Vex, Rex, and iRex): novel predictors and late toxicity correlations in cervical cancer image-guided adaptive brachytherapy","volume":"12","author":"Prasartseree","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.clon.2025.103907_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1016\/j.clon.2025.103907_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5114\/jcb.2018.78993","article-title":"Comparison of impact of target delineation of computed tomography- and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer","volume":"10","author":"Tuntipumiamorn","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.clon.2025.103907_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group\u2606 (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2011.12.024","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy","volume":"103","author":"Dimopoulos","year":"2012","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)","volume":"97","author":"Mell","year":"2017","journal-title":"International Journal of Radiation Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2025.103907_bib32","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP n.d. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50 (accessed February 21, 2023)."},{"key":"10.1016\/j.clon.2025.103907_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2020.08.044","article-title":"Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study","volume":"109","author":"Vittrup","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2025.103907_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2025.103907_bib36","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cncr.22217","article-title":"The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24","volume":"107","author":"Greimel","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2010.08.014","article-title":"Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)","volume":"47","author":"Greimel","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2025.103907_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.clon.2025.103907_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.conctc.2017.04.008","article-title":"Design of phase II non-inferiority trials","volume":"7","author":"Jung","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.clon.2025.103907_bib40","series-title":"ART: stata module to compute sample size and power for complex randomised trial designs with binary or time-to-event outcomes","author":"Babiker","year":"2022"},{"key":"10.1016\/j.clon.2025.103907_bib41","series-title":"STSURVDIFF: Stata module to compute difference in Kaplan-Meier survival curves","author":"Royston","year":"2011"},{"key":"10.1016\/j.clon.2025.103907_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40814-016-0105-8","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"2","author":"Eldridge","year":"2016","journal-title":"Pilot and Feasibility Studies"},{"key":"10.1016\/j.clon.2025.103907_bib43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gore.2018.06.007","article-title":"Advancing clinical research globally: Cervical cancer research network from Mexico","volume":"25","author":"Ager","year":"2018","journal-title":"Gynecologic Oncology Reports"},{"key":"10.1016\/j.clon.2025.103907_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2020.05.032","article-title":"Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic","volume":"148","author":"Mendez","year":"2020","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103907_bib45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/0284186X.2022.2048070","article-title":"Phase 1\/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT)","volume":"61","author":"Bacorro","year":"2022","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.clon.2025.103907_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"The Lancet Oncology"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:17:41Z","timestamp":1758082661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525001621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":46,"alternative-id":["S0936655525001621"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103907","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy\/ 20 F vs 45 Gy\/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial)","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103907"}}